Biolife Solutions (BLFS) Invested Capital (2019 - 2026)

Biolife Solutions (BLFS) has 8 years of Invested Capital data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Invested Capital fell 76.08% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $25.0 million, a 4.59% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, down 54.34% from the prior year.
• Invested Capital for Q1 2026 stood at $2.5 million, down from $5.0 million in the prior quarter.
• Over the last five years, Invested Capital for BLFS reached as high as $10.9 million in Q4 2024 and fell as low as $256000.0 in Q1 2023.
• Historically, Invested Capital has averaged $3.4 million across 5 years, with a median of $1.5 million in 2023.
• Across the five-year window, Invested Capital surged 665.5% in 2025 and plunged 76.08% in 2026, its largest moves.
• Year by year, Invested Capital stood at $284000.0 in 2022, then jumped by 444.01% to $1.5 million in 2023, then jumped by 608.28% to $10.9 million in 2024, then sank by 54.34% to $5.0 million in 2025, then plunged by 49.99% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $2.5 million in Q1 2026, $5.0 million in Q4 2025, and $7.5 million in Q3 2025.